Findlay Park Partners’s Medtronic MDT Stock Holding History

Findlay Park Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,500,000	Closed	-$121M	–	61
2017 Q1	$121M	Sell	1,500,000 -650,000	-30%	-$50.8M	1.28%	33
2016 Q4	$153M	Sell	2,150,000 -1,465,000	-41%	-$115M	1.86%	22
2016 Q3	$312M	Buy	3,615,000 +465,000	+15%	+$40.5M	3.62%	5
2016 Q2	$273M	Sell	3,150,000 -386,324	-11%	-$31.2M	3.13%	11
2016 Q1	$265M	Buy	3,536,324 +336,324	+11%	+$25.3M	3.01%	11
2015 Q4	$246M	Buy	3,200,000 +350,000	+12%	+$26.3M	2.8%	12
2015 Q3	$191M	Buy	2,850,000 +400,000	+16%	+$29.5M	2.12%	14
2015 Q2	$182M	Buy	2,450,000 +300,000	+14%	+$22.9M	1.86%	14
2015 Q1	$168M	Buy	2,150,000 +916,625	+74%	+$69.5M	1.75%	15
2014 Q4	$89M	Sell	1,233,375 -78,000	-6%	-$5.42M	0.95%	43
2014 Q3	$81.2M	Buy	1,311,375 +429,000	+49%	+$27.3M	0.87%	48
2014 Q2	$56.3M	Buy	+882,375	New	+$53.6M	0.58%	72

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Findlay Park Partners's MDT Position: Q2 2017 in Review

Findlay Park Partners sold out of Medtronic (MDT) in Q2 2017, closing a stake of 1,500,000 shares — an estimated $121M sold.

Findlay Park Partners first reported a position in MDT in Q2 2014 and held it in 12 quarters. The position peaked at $312M in Q3 2016. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

Findlay Park Partners reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
Findlay Park Partners sold 1,500,000 Medtronic shares in Q2 2017, an estimated $121M.
Findlay Park Partners first reported a position in Medtronic in Q2 2014 and held it in 12 quarters.
Findlay Park Partners's Medtronic position peaked at $312M in Q3 2016.
1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Findlay Park Partners's 13F filing for Q2 2017, filed 10 Aug 2017.